Cited by 112Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesDiabetes Treatment and Management

Ghrelin, obesity and diabetes

Wiedmer, Petra, Nogueiras, Rubén, Broglio, Fabio, D'Alessio, David, Tschöp, Matthias H·2007·Nature Clinical Practice Endocrinology & Metabolism

Abstract

The high prevalence of obesity and diabetes will lead to higher rates of morbidity and mortality. The search for drugs to treat these metabolic disorders has, therefore, intensified. The stomach-derived peptide ghrelin regulates food intake and body weight. Recent work suggests that ghrelin also controls glucose metabolism. In addition, current evidence suggests that most of the actions of ghrelin could contribute to the metabolic syndrome. The ghrelin signaling system is, therefore, a promising target for the development of new drugs for the treatment of obesity and diabetes. Agents that block the ghrelin signaling system might be especially useful targets. This Review summarizes the potential and the limitations of ghrelin as a tool to better understand, prevent and treat obesity and diabetes.

Integrity signals

Registry

Crossref · 10.1038/ncpendmet0625

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased GLP-1 and PYY levels together with an absence of a compensatory rise in ghrelin in most RYGB patients would be expected to favor improved insulin sensitivity.

    “Increased GLP-1 and PYY levels together with an absence of a compensatory rise in ghrelin in most RYGB patients would be expected to favor improved insulin sensitivity as these hormone affect glucose homeostasis in addition to appetitive behavior (8, 30–32).”

Cites

Flagged first, then by citations

1 of the 94 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Wiedmer, P., Nogueiras, R., Broglio, F., D'Alessio, D., & Tschöp, M. H.
Affiliations
  • German Institute of Human Nutrition (DE)
  • University of Cincinnati (US)
  • University of Turin (IT)
Corresponding author
Tschöp, Matthias H
Venue
Nature Clinical Practice Endocrinology & Metabolism
Published
2007-10
Volume
3
Issue
10
Pages
705-712
ISSN
  • 1745-8366 (ISSN-L)
  • 1745-8374
OpenAlex
W2021729437
Cited by
111
References
94
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 4 · 2018: 7 · 2017: 2 · 2016: 9 · 2014: 10 · 2013: 8 · 2012: 9
FWCI
0.81
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
ghrelin, obesity, type 2 diabetes, glucose homeostasis, growth hormone secretagogue receptor, energy balance, dietary intake, metabolic syndrome, ghrelin signaling, anti-obesity drugs, antidiabetic drugs
MeSH terms
Animals, Blood Glucose, Diabetes Mellitus, Energy Metabolism, Humans, Obesity, Peptide Hormones, Ghrelin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review